Navigation Links
Scott & White Healthcare -- Round Rock performing surgery without incisions for heartburn

Millions of Americans, or 10 percent of the population, suffers from daily heartburn or other symptoms of reflux such as regurgitation, chronic cough, hoarseness and dental erosions. Until recently, many of these patients faced either a lifetime of daily medications, incomplete resolution, or worsening of their symptoms while treatment options were often limited to surgery. Scott & White Healthcare Round Rock is offering a new procedure to patients who meet specific requirements and are generally not doing well on daily medications known as Proton Pump Inhibitors (PPIs). The procedure is called the Transoral Incisionless Fundoplication, or TIF, which uses the EsophyX device and is performed without incisions.

"Most patients who have chronic heartburn or GERD find that their condition is well controlled with medications like PPIs; the TIF procedure, on the other hand, is an option for those patients who do not do well on daily medications or those who have concerns about the implications of lifelong pill therapy like cost and side effects," said F. Paul "Tripp" Buckley, III, MD, general surgeon at Scott & White Round Rock. "For the right patient, TIF can improve quality of life and having a multi-disciplinary, integrated team of specialists in place at Scott & White also allows for the highest quality medical care for the patient," said Dr. Buckley. "Scott & White is unique in that we have a surgeon and a gastroenterologist working side-by-side as a team to perform the procedure."

Dr. Buckley goes on to explain, "Gastroesophageal Reflux Disease (GERD) is a mechanical/anatomic problem and reflux medication like PPIs help relieve the majority of patients' heartburn symptoms. Some patients, however, continue to have symptoms despite maximum medical therapy. Others may have complications, and or, contraindications to long-term PPI use, while some patients don't want to be on lifelong medications or can't afford them. For these patients, a mechanical fix is needed. And, traditionally, this has meant a major surgical procedure (most commonly a laparoscopic Nissen Fundoplication). With the advent of the TIF procedure, the traditional surgery can be duplicated without any incisions."

Laparoscopy, a form of "minimally invasive surgery," typically requires from three to five- port holes with the same internal incisions as open surgery. TIF, on the other hand, is considered "minutely invasive" requiring no incisions.

"The TIF procedure recreates the anti-reflux barrier between the esophagus and stomach and is performed trans-orally (through the mouth)," said Benjamin Havemann, MD, gastroenterologist at Scott & White Round Rock. "The procedure can reduce a small hiatal hernia and creates a valve between the stomach and esophagus restoring the natural, physiological anatomy to prevent reflux. Because the procedure is incisionless, there is reduced pain, shorter recovery time required, and no visible scar."

Recent studies show that TIF can reduce patients' dependency on medications with 80 percent of patients remaining off their daily medications after two years and experiencing an improvement in their quality of life. After the TIF procedure, clinical trials show that many patients can eat and drink foods they avoided for years.

Dr. Havemann, director of the division of gastroenterology, routinely performs a variety of advanced endoscopic procedures.

Dr. Buckley, director of general surgery, was the first surgeon in the Central Texas region to perform a Single-Incision Laparoscopic (SILS) Nissen Fundoplication, a technique performed with a single incision in the belly button to treat esophageal reflux (GERD). Surgeons from around the country have been trained by Dr. Buckley on this and many other SILS procedures. To learn more visit, SILS.SW.ORG.


Contact: Katherine Voss
Scott & White Healthcare

Related medicine news :

1. Scott & White Memorial Hospital uses device to revolutionize treatment of traumatic aortic injury
2. Scott & White Healthcare pathologist is co-investigator on breast cancer study
3. James Scott Farrin Supports Radiothon for Duke Children's Hospital
4. SUNZ Insurance Company Selects Scott Robertson as President
5. Allergy Relief, Chiropractic and Biofeedback Provided at New Absolute Health Clinic in Scottsdale, Arizona
6. Scott & White Healthcare researchers studying investigational agent that targets breast cancer
7. New Varicose Vein Treatment Center Opens in Prescott, Arizona
8. Scottsdale Veterinary Pharmacy Celebrates Success in Business By Dodging Veterinary Drug Shortages
9. Scott & White Healthcare clinical trials target lymphoma, leukemia
10. Scott & White Healthcare physician to help develop global guidelines for Alzheimers
11. Scott Harter at Atrion International Receives EHS Gold Award From PPG Industries
Post Your Comments:
(Date:12/1/2015)... ... ... Growth in medical payments per workers’ compensation claim in Louisiana slowed from 2011 ... according to a recent study by the Workers Compensation Research Institute (WCRI). , ... per claim with more than seven days of lost time continued to be higher ...
(Date:12/1/2015)... Wayland, MA (PRWEB) , ... December 01, 2015 , ... ... adults has a tattoo — a number even greater among Millennials (a whopping one ... there are more and more people who are dissatisfied with their ink. In fact, ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... technicians must mark the film for accurate interpretation by the radiologist. The marking ... an inventor from Sacramento, Calif., has found a way to alleviate this problem. ...
(Date:12/1/2015)... ... 01, 2015 , ... Next IT Healthcare, the leader in ... this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher ... in the category of Digital Solutions for its innovative, industry-leading product, Alme Health ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Effective Post-Affiliation Integration ,” addresses a main “pain point” for merging or aligning ... results, once a deal is signed. This quick-read guidance suggests that failing ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 1, 2015 Relmada Therapeutics, Inc. ... treatment of chronic pain, announced today that the company will ... be held December 1-3 at the Luxe Sunset Boulevard Hotel ... Traversa , CEO of Relmada Therapeutics, will present on Thursday, ... Time). . Please register at least 10 ...
(Date:12/1/2015)... 2015 CytRx Corporation (NASDAQ: CYTR ), ... today announced that it has reached its enrollment target ... 3 clinical trial of aldoxorubicin in patients with previously ... be completed in Q1 2016. The Phase 3 trial is ... Protocol Assessment from the FDA at 79 sites in ...
(Date:12/1/2015)... , Dec. 1, 2015  Today, ... the launch of CareFront, a first-of-its-kind population health ... diagnosed with cancer. Designed to be built into ... cancer patients with resources for their care and ... program also offers tools to help patients understand ...
Breaking Medicine Technology: